Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa

Ndayisaba, Gilles; Yeka, Adoke; Asante, Kwaku Poku; Grobusch, Martin P.; Karita, Etienne; Mugerwa, Henry; Asiimwe, Stephen; Oduro, Abraham; Fofana, Bakary; Doumbia, Seydou; Jain, Jay Prakash; Barsainya, Sarita; Kullak-Ublick, Gerd A.; Su, Guoqin; Schmitt, Esther K.; Csermak, Katalin; Gandhi, Preetam; Hughes, David

dc.contributor.author	Grobusch, Martin
dc.date.accessioned	2022-07-14T06:52:39Z
dc.date.available	2022-07-14T06:52:39Z
dc.date.issued	2021
dc.identifier.issn	1475-2875
dc.identifier.uri	http://hdl.handle.net/10900/129379
dc.language.iso	en	en
dc.publisher	London	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s12936-021-04009-1
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00088
utue.personen.roh	Ndayisaba, Gilles
utue.personen.roh	Yeka, Adoke
utue.personen.roh	Asante, Kwaku Poku
utue.personen.roh	Grobusch, Martin P.
utue.personen.roh	Karita, Etienne
utue.personen.roh	Mugerwa, Henry
utue.personen.roh	Asiimwe, Stephen
utue.personen.roh	Oduro, Abraham
utue.personen.roh	Fofana, Bakary
utue.personen.roh	Doumbia, Seydou
utue.personen.roh	Jain, Jay Prakash
utue.personen.roh	Barsainya, Sarita
utue.personen.roh	Kullak-Ublick, Gerd A.
utue.personen.roh	Su, Guoqin
utue.personen.roh	Schmitt, Esther K.
utue.personen.roh	Csermak, Katalin
utue.personen.roh	Gandhi, Preetam
utue.personen.roh	Hughes, David
dcterms.isPartOf.ZSTitelID	Malaria Journal	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	20	de_DE
utue.fakultaet	Universität Tübingen (ohne Fakultätsangabe)